Table 1
Toxoplasma IgG commercial methods included: type of assay, number of evaluation studies, and population studied.
Technique | Firm | Type of method | Threshold (IU/mL) | No of studies | Population studied | No of sera | No of IgG-positive | References |
---|---|---|---|---|---|---|---|---|
Access Toxo IgG II® | Beckman Coulter Inc. | MEIA, automated | 7.5 ≤ x < 10.5 | 2 | Pregnant women | 760 | 257 | [4, 14] |
Low IgG | ||||||||
Advia Centaur Toxo IgG® | Siemens Healthineers | CMIA, automated£ | 6.4 < x ≤ 10 | 1 | Miscellaneous | 406 | 207 | [24] |
Architect Toxo IgG® | Abbott | MEIA, automated£ | 1.6 ≤ x < 3 | 5 | Pregnant women | 2992 | 773 | [4, 7, 13, 16, 24] |
Low IgG | ||||||||
Miscellaneous | ||||||||
AxSYM Toxo IgG® | Abbott | MEIA, automated£ | 2 ≤ x < 3 | 3 | Pregnant women | 1555 | 638 | [7, 14, 24] |
Miscellaneous | ||||||||
BioPlex 2200 ToRCH IgG/IgM® | BioRad | MFA, automated | 9 ≤ x < 12 | 1 | Miscellaneous | 162 | 139 | [9] |
Elecsys Toxo IgG® | Roche Diagnostics | ECLIA, automated£ | 1 ≤ x < 30 | 5 | Pregnant women | 2214 | 1398 | [4, 14, 18, 23, 24] |
Low IgG | ||||||||
Miscellaneous | ||||||||
Immulite 2000 anti-Toxoplasma IgG® | Siemens Healthineers | MEIA, automated | 6 ≤ x < 8 | 2 | Miscellaneous | 655 | 348 | [14, 19] |
Pregnant women | ||||||||
Liaison Toxo IgG II® | Diasorin | CMIA, automated£ | 7.2 ≤ x < 8.8 | 4 | Low IgG | 1381 | 460 | [4, 16, 23, 24] |
Miscellaneous | ||||||||
OnSite Toxo IgG/IgM Combo Rapid Test® | CTK Biotech | ICT, manual£ | 1 | Miscellaneous | 310 | 170 | [8] | |
Pastorex® | BioRad | Agglutination£ | 1 | Miscellaneous | 589 | 344 | [26] | |
Platelia Toxo IgG® | BioRad | Microplate ELISA, automated£ | 6 ≤ x < 8 | 3 | Low IgG | 1436 | 491 | [4, 10, 24] |
Miscellaneous | ||||||||
TGS TA Toxo IgG/IDS-iSYS® | TGS Technogenetics | MEIA, automated | >1.5 | 2 | Low IgG | 1137 | 319 | [4, 12] |
Miscellaneous | ||||||||
Toxo IgG/IgM Rapid Test® | Biopanda Reagents | ICT, manual£ | 1 | Miscellaneous | 310 | 170 | [8] | |
Toxocell® | Biokit | Agglutination£ | 1 | Miscellaneous | 589 | 344 | [26] | |
Toxo HAI® | Fumouze | Hemagglutination£ | 1 | Miscellaneous | 589 | 344 | [26] | |
Toxolatex® | Fumouze | Agglutination£ | 1 | Miscellaneous | 589 | 344 | [26] | |
Toxoplasma ICT IG/IgM® | LDBio | ICT, manual£ | 3 | Low IgG | 1492 | 559 | [2, 8, 13] | |
Miscellaneous | ||||||||
Vidas Toxo IgG® | BioMérieux | ELFA, automated£ | 4 ≤ x < 8 | 7 | Low IgG | 3368 | 1093 | [4, 7, 10, 14, 16, 23, 24] |
Miscellaneous | ||||||||
Pregnant women | ||||||||
Vitros ECiQ Toxoplasma IgG® | Ortho Diagnostics | CLIA£ | 4 ≤ x < 8 | 1 | Pregnant women | 719 | 551 | [11] |
WB Toxo IgGII® | LDBio | WB, manual£ | 1 | Low IgG | 569 | 162£ | [5] | |
Miscellaneous |
ELISA: enzyme-linked immuno-sorbent assay, MEIA: microparticle enzyme immunoassay, ELFA: enzyme-linked fluorescent assay, CLIA: chemiluminescence immunoassay, CMIA: chemiluminescent microparticle immunoassay, ECLIA: electrochemiluminescence immunoassay, MFA: Multiplex fluorescence assay, WB: western-blot assay, ICT: immunochromatographic assay.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.